StonvexLoading…
StonvexStonvexStonvexCore line items from FRHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $97.45M | $66.37M | $37.22M | $17.22M |
Operating Income | $225.97M | $194.95M | $101.00M | $40.52M |
Net Income | $153.33M | $145.35M | $69.12M | $30.40M |
EPS (Diluted) | $2.51 | $2.38 | $1.13 | $0.50 |
Total Assets | $13.16B | $12.38B | $10.35B | $9.69B |
Total Liabilities | $11.67B | $10.98B | $9.13B | $8.46B |
Cash & Equivalents | $966.12M | $869.17M | $635.98M | $567.91M |
Free Cash Flow OCF − CapEx | $-13.54M | $1.56B | $906.40M | $450.04M |
Shares Outstanding | 61.29M | 61.18M | 61.16M | 61.21M |